Since the publication of the first edition, chronic obstructive pulmonary disease (COPD), as a public health issue, has increased in line with the predictions of the World Health Organization and by the year 2020, will become one of the main killers of human life.
With several important large scaled trials becoming available and our knowledge of COPD's determinants rapidly growing, it was essential to update Clinical Management of Chronic Obstructive Pulmonary Disease with a second edition that will enable physicians to stay informed, aid in the clinical diagnosis, and the proper treatment of COPD
Within this text expert analysis will examine:
new treatments and combative strategies developed from recent and current clinical trails
the pathological and physiological mechanisms of chronic obstructive pulmonary disease
current and up to date information from developing worlds faced with the COPD epidemic
the burden COPD has and will have in the future for patients, treatments and society
Auflage
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für höhere Schule und Studium
Editions-Typ
Maße
Höhe: 229 mm
Breite: 152 mm
Gewicht
ISBN-13
978-0-367-38826-3 (9780367388263)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Stephen I. Rennard, Roberto Rodriguez-Roisin, Gerard Huchon, Nicolas Roche
PART I: UNDERSTANDING COPD AND ITS IMPACT. 2.Smoking Cessation. 3. The Relationship of Tobacco Smoking to COPD: Histopathogenesis. 4. COPD as a Systemic Disease. PART II: ASSESSING COPD. 5. Early Diagnosis of COPD: Usefulness, Tools, and Actors. 6. Assessment of Symptoms and Quality of Life in the.COPD Patient. 7. Measuring Ventilatory and Respiratory Impairment in COPD. 8. Imaging of Lung Morphology and Function in COPD. 9. Assessing the Systemic Consequences of COPD. 10. The Pulmonary Vasculature of COPD. 11. How the COPD Patient Should Be Assessed for Comorbidities .12. Goals of COPD Treatments and Measurement of Their Ef?cacy: From Clinical Trials to Real-World Practice. PART III: PHARMACOLOGICAL TREATMENTS OF COPD. 13. Choosing the Right Bronchodilator. 14. When Should We Use Glucocorticoids in COPD? 15. Treating and Preventing Infections. 16. Phosphodiesterase 4 Inhibitors, Mucolytics, and Emerging Pharmacotherapies for COPD. 17. Managing Exacerbations: An Overview. PART IV: NONPHARMACOLOGICAL APPROACHES IN COPD. 18. Exercise Training in COPD. 19. New Components of Pulmonary Rehabilitation in COPD. 20. Long-Term Oxygen Therapy for the Patient with COPD. 21. Noninvasive Ventilation in COPD. 22. Surgical Therapy for COPD. 23. Perioperative Medical Management for Patients with COPD: The Anesthesiologist's View. 24. Providing Palliative and End-of-Life Care for Patients.with COPD. PART V: CONCLUSION. 25. A Global Strategy for a Global Disease. 26. Caring for the Patient with COPD: A Practical Summary of Guidelines for Clinicians
